Nyah Shah

Nyah Shah

Auto-generated profile, based on publicly available information

Nyah Shah

Department of Health Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2023 in PLOS Climate
Verified
Journal Article
Open access
PDF file
PCPaige Cheveldayoff
Paige Cheveldayoff
FCFariha Chowdhury
Fariha Chowdhury
NSNyah Shah
Nyah Shah
CBCarly Burow
Carly Burow
MFMelanie Figueiredo
Melanie Figueiredo
LHLee Hill
Lee Hill
The ability to regulate core body temperature is a critical factor in avoiding occupational heart stress in demanding environments. Heat-related illness in an occupational setting is complex and multifactorial and includes environment (intrinsic and extrinsic), the occupational clothing requirements and physiological factors. Much of this research began in the gold mines in South Africa after several miners died due to heat related illness. Similar research was conducted during World War Two and was crucial for the creation of acclimatization techniques and strategies for acquiring thermal tolerance. Techniques such as fatigue recovery and body cooling are still used today to prevent heat related illness in individuals with occupations that have frequent exposure to heat and high physical loads. These individuals are at greater risk of heat related illness as extended exposure to a hot or humid environment in combination with strenuous physical activity can overwhelm the body’s homeostatic cooling mechanisms. In addition, individuals from special populations with chronic or acute health impacts such as diabetes mellitus, also have a greater risk for the aforementioned. Currently, there are several heat prevention strategies, including training and education, regulation and monitoring, in place to protect workers from heat related illness and casualty. These strategies, along with future considerations and the impact of climate change will be highlighted in this review.

12 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Upendar Rao GollaUpendar Rao Golla
Upendar Rao Golla
Satyam Devang PatelSatyam Devang Patel
Satyam Devang Patel
NSNyah Shah
Nyah Shah
STStella Talamo
Stella Talamo
RBRiya Bhalodia
Riya Bhalodia
ASArati Sharma
Arati Sharma
Drug repurposing is a strategy to discover new therapeutic uses for existing drugs, which have well-established toxicity profiles and are often more affordable. This approach has gained significant attention in recent years due to the high costs and low success rates associated with traditional drug development. Drug repositioning offers a more time- and cost-effective path for identifying new treatments. Several FDA-approved non-chemotherapy drugs have been investigated for their anticancer potential. Among these, anthelmintic benzimidazoles (such as albendazole, mebendazole, and flubendazole) have garnered interest due to their effects on microtubules and oncogenic signaling pathways. Blood cancers, which frequently develop resistance and have high mortality rates, present a critical need for effective therapies. This review highlights the recent advances in repurposing benzimidazoles for blood malignancies. These compounds induce cell cycle arrest, differentiation, tubulin depolymerization, loss of heterozygosity, proteasomal degradation, and inhibit oncogenic signaling to exert their anticancer effects. We also discuss current limitations and strategies to overcome them, emphasizing the potential of combining benzimidazoles with standard therapies for improved treatment of hematological cancers.